The AGITG ICECREAM STUDY: The Irinotecan Cetuximab Evaluation and Cetuximab Response Evaluation Amongst Patients with a G13D Mutation

Eva Segelov, Kate Wilson, Val Gebski, Paul Waring, Jayesh Desai, Louise Nott, Christos Karapetis, Harpreet Wasan, Jeremy Shapiro

Research output: Contribution to conference › Poster

Filter

2015

The AGITG ICECREAM STUDY: The Irinotecan Cetuximab Evaluation and Cetuximab Response Evaluation Amongst Patients with a G13D Mutation- analysis of outcomes in patients with refractory metastatic colorectal cancer harbouring the KRAS G13D mutation.
Segelov, E., Thavaneswaran, S., Waring, P., Desai, J., Mann, K., Elez, M. E., Chantrill, L. A., Pavlakis, N., Nott, L., Underhill, C., Khasraw, M., Wasan, H., Ciardiello, F., Jefford, M. J., Joubert, W., Haydon, A. M. M., Karapetis, C., Price, T. J., Wilson, K. & Shapiro, J., 2015, p. S726. 1 p.
Research output: Contribution to conference › Abstract

Research output